Cargando…

The Relationships between cyclin D1 Expression and Prognosis of Non-small Cell Lung Cancer

BACKGROUND AND OBJECTIVE: cyclin D1 is a member of the cyclin family, and it has been proven that it plaied an important role in tumorigenesis, invasion and metastasis. We performed a retrospective study on the cyclin D1 expression in non-small cell lung cancer (NSCLC) according to the clinical char...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHU, Jiping, YU, Like, ZHAN, Ping, SONG, Yong, WANG, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	中国肺癌杂志编辑部 2010
Materias:	Clinical Experiences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000561/ https://www.ncbi.nlm.nih.gov/pubmed/20704822 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.08.10

Ejemplares similares

Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer
por: Keum, J S, et al.
Publicado: (1999)

Flattened microvessel independently predicts poor prognosis of patients with non-small cell lung cancer
por: Fang, Luo, et al.
Publicado: (2017)

Galectin-3 and cyclin D1 expression in non-small cell lung cancer
por: Kosacka, Monika, et al.
Publicado: (2011)

The Relationship between MACC1/c-Met/Cyclin D1 Axis Expression and Prognosis in ESCC
por: Shi, Yan, et al.
Publicado: (2022)

Surgical Therapeutic Strategy for Non-small Cell Lung Cancer with Mediastinal Lymph Node Metastasis (N2)
por: MA, Qianli, et al.
Publicado: (2010)

Long Distance From Microvessel to Cancer Cell Predicts Poor Prognosis in Non-Small Cell Lung Cancer Patients
por: Ding, Haiying, et al.
Publicado: (2021)

Cyclin-dependent kinase 15 upregulation is correlated with poor prognosis for patients with breast cancer
por: Zhang, Xiquan, et al.
Publicado: (2021)

Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer
por: Zhu, Bojin, et al.
Publicado: (2018)

Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
por: Sun, Wenze, et al.
Publicado: (2013)

Cyclin D1 expression in prostate carcinoma
por: Pereira, R.A., et al.
Publicado: (2014)

CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis
por: Yang, Yong, et al.
Publicado: (2021)

Cyclin D1, cyclin E, and p21 have no apparent prognostic value in anal carcinomas treated by radiotherapy with or without chemotherapy
por: Allal, A S, et al.
Publicado: (2004)

Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer
por: Poikonen, P, et al.
Publicado: (2005)

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer
por: Kubo, Hiroshi, et al.
Publicado: (2014)

Low level of Cyclin‐D1 correlates with worse prognosis of clear cell renal cell carcinoma patients
por: Wang, Qing‐shui, et al.
Publicado: (2019)

Prognosis of Recurrence after Complete Resection in Early-Stage Non-Small Cell Lung Cancer
por: Choi, Pil Jo, et al.
Publicado: (2013)

Treatment and prognosis after progression in long-term responders to EGFR-tyrosine kinase inhibitor in advanced non-small cell lung cancer
por: Song, Zhengbo, et al.
Publicado: (2016)

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.
por: Betticher, D. C., et al.
Publicado: (1996)

miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer
por: Yu, Xiaojie, et al.
Publicado: (2018)

Cyclin D1 expression in KRAS mutant non-small cell lung cancer—old wine into new skins
por: Goh, Kah Yee, et al.
Publicado: (2020)

Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1
por: Zhang, Zhiwei, et al.
Publicado: (2021)

LncRNA MIR503HG Inhibits Non-Small Cell Lung Cancer Cell Proliferation by Inducing Cell Cycle Arrest Through the Downregulation of Cyclin D1
por: Xu, Shufen, et al.
Publicado: (2020)

Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas.
por: Volm, M., et al.
Publicado: (1997)

The Prognosis According to Patterns of Mediastinal Lymph Node Metastasis in Pathologic Stage IIIA/N2 Non-Small Cell Lung Cancer
por: Kim, Do Wan, et al.
Publicado: (2014)

The relationship between chronic obstructive pulmonary disease and non‐small cell lung cancer in the elderly
por: Wang, Peng, et al.
Publicado: (2019)

Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia
por: HANAFI, Arif R, et al.
Publicado: (2020)

Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer
por: Shan, Yan-Shen, et al.
Publicado: (2017)

Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer
por: Lin, Rui Jun, et al.
Publicado: (2013)

Expression of THOP1 and Its Relationship to Prognosis in Non-Small Cell Lung Cancer
por: Qi, Lei, et al.
Publicado: (2014)

Correlations of Twist Expression with Pathological and Computed Tomography (CT) Characteristics and Prognosis of Non-Small Cell Lung Cancer (NSCLC)
por: Duan, Feng, et al.
Publicado: (2019)

Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study
por: Tamiya, Akihiro, et al.
Publicado: (2020)

Inhibition of Cyclin D1 Expression and Induction of Apoptosis by Inostamycin in Small Cell Lung Carcinoma Cells
por: Imoto, Masaya, et al.
Publicado: (1998)

RACK1 is a candidate gene associated with the prognosis of patients with early stage non-small cell lung cancer
por: Choi, Yi-Young, et al.
Publicado: (2015)

Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer
por: Ma, Jun, et al.
Publicado: (2017)

The Position of Neutrophils-To-Lymphocytes and Lymphocytes-To-Platelets Ratio as Predictive Markers of Progression and Prognosis in Patients with Non-Small Cell Lung Cancer
por: Minkov, Plamen, et al.
Publicado: (2018)

Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer
por: Myklebust, M P, et al.
Publicado: (2012)

LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer
por: Wang, Lu, et al.
Publicado: (2021)

Short- and long-term outcomes in elderly patients with locally advanced non-small-cell lung cancer treated using video-assisted thoracic surgery lobectomy
por: Zhang, Like
Publicado: (2018)

Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non‐small cell lung cancer harboring EGFR mutation
por: Kodama, Hiroaki, et al.
Publicado: (2021)

Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non‐small cell lung cancer
por: Deng, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_drlb0fo9shgiqs2496quifs8d9